PL EN


Preferences help
enabled [disable] Abstract
Number of results
2018 | 133 | 2 | 306-308
Article title

Genotoxicity Study of Carbon Nanoforms using a Comet Assay

Content
Title variants
Languages of publication
EN
Abstracts
EN
Carbon nanoforms due to their unique properties can be applied in many areas also in medicine. This article presents preliminary genotoxicity studies of electrospun carbon nanofibers (ECNF). This material, apart from its numerous applications, may also be a candidate for use in medical therapy and diagnostics. Polyacrylonitrile (PAN) nanofibers received in the electrospinning process were carbonized and thereafter subjected to oxidation treatment (ECNF-F). Both types of fibres were analyzed with regard to genotoxic influence on the fibroblast line cells using comet assay. Additionally, comet assay experiments were conducted on biocompatible carbon nanotubes with a hydrophilic surface. The results indicate the key role of the oxidation process in the functionalization of carbon nanoparticles intended for medical purposes.
Keywords
EN
Contributors
author
  • Institute of Nuclear Physics, Polish Academy of Sciences, PL-31342 Krakow, Poland
  • AGH University of Science and Technology, Faculty of Materials Science and Ceramics, PL 30059 Krakow, Poland
author
  • AGH University of Science and Technology, Faculty of Materials Science and Ceramics, PL 30059 Krakow, Poland
author
  • AGH University of Science and Technology, Faculty of Materials Science and Ceramics, PL 30059 Krakow, Poland
  • Institute of Nuclear Physics, Polish Academy of Sciences, PL-31342 Krakow, Poland
  • AGH University of Science and Technology, Faculty of Materials Science and Ceramics, PL 30059 Krakow, Poland
References
  • [1] K.S. Ibrahim, Carbon Lett. 14, 131 (2013), doi: 10.5714/CL.2013.14.3.131
  • [2] M. Pacios Pujadó, Carbon nanotubes as platforms for biosensors with electrochemical and electronic transduction, Springer, Berlin 2012, p. 1 http://springer.com/gp/book/9783642314209
  • [3] P.A. Tran, L. Zhang, T.J. Webster, Adv. Drug Deliv. Rev. 61, 1097 (2009), doi: 10.1016/j.addr.2009.07.010
  • [4] D.A. Stout, B. Basu, T.J. Webster, Acta Biomater. 7, 3101 (2011), doi: 10.1016/j.actbio.2011.04.028
  • [5] L. Zhang, A. Aboagye, A. Kelkar, C. Lai, H. Fong, J. Mater. Sci. 49, 463 (2014), doi: 10.1007/s10853-013-7705-y
  • [6] A.A. Shvedova, A. Pietroiusti, B. Fadeel, V.E. Kagane, Toxicol. Appl. Pharmacol. 261, 121 (2012), doi: 10.1016/j.taap.2012.03.023
  • [7] K. Kostarelos, Nature Biotechnol. 26, 774 (2008), doi: 10.1038/nbt0708-774
  • [8] P. Musioł, P. Szatkowski, M. Gubernat, A. Wesełucha-Birczyńska, S. Błażewicz, Ceram. Int. 42, 11603 (2016), doi: 10.1016/j.ceramint.2016.04.055
  • [9] A. Cebulska-Wasilewska, A. Panek, Z. Zabinski, P. Moszczynski, W.W. Au, Mutat. Res. 586, 102 (2005), doi: 10.1016/j.mrgentox.2005.06.009
  • [10] A. Cebulska-Wasilewska, I. Pawłyk, A. Panek, A. Wiecheć, I. Kalina, T. Popov, T. Georgieva, P.B. Farmer, Mutat. Res. 620, 145 (2007), doi: 10.1016/j.mrfmmm.2007.03.004
  • [11] A. Fraczek-Szczypta, E. Menaszek, S. Blazewicz, J. Nanomater. 2011, 473516 (2011), doi: 10.1155/2011/473516
  • [12] E.R. Kisin, A.R. Murray, L. Sargent, D. Lowry, M. Chiril, K.J. Siegrist, D. Schwegler-Berry, S. Leonard, V. Castranova, B. Fadeel, V.E. Kagan, A.A. Shvedova, Toxicol. Appl. Pharmacol. 252, 1 (2011), doi: 10.1016/j.taap.2011.02.001
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-app133z2p22kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.